Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy
- PMID: 23833698
- PMCID: PMC3523102
- DOI: 10.1007/s12177-012-9091-0
Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy
Abstract
Diabetic retinopathy represents the most common causes of vision loss in patients affected by diabetes mellitus. The cause of vision loss in diabetic retinopathy is complex and remains incompletely understood. One of the earliest changes in the development of retinopathy is the accelerated apoptosis of retinal microvascular cells and the formation of acellular capillaries by unknown mechanism. Results of a recent research suggest an important role of matrix metalloproteinases (MMPs) in the development of diabetic retinopathy. MMPs are a large family of proteinases that remodel extracellular matrix components, and under pathological condition, its induction is considered as a negative regulator of cell survival; and in diabetes, latent MMPs are activated in the retina and its capillary cells, and activation of MMP-2 and -9 induces apoptosis of retinal capillary cells. This review will focus on the MMP-2 and MMP-9 in the diabetic retina with special reference to oxidative stress, mitochondria dysfunction, inflammation and angiogenesis, as well as summarizing the current information linking these proteins to pathogenesis of diabetic retinopathy.
Keywords: Angiogenesis; Apoptosis; Diabetic retinopathy; Inflammation; MMP-2; MMP-9; Oxidative stress.
Similar articles
-
Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.Expert Opin Investig Drugs. 2012 Jun;21(6):797-805. doi: 10.1517/13543784.2012.681043. Epub 2012 Apr 23. Expert Opin Investig Drugs. 2012. PMID: 22519597 Free PMC article. Review.
-
Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?Curr Protein Pept Sci. 2019;20(4):324-333. doi: 10.2174/1389203719666180914093109. Curr Protein Pept Sci. 2019. PMID: 30215334 Review.
-
Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.Diabetes. 2011 Nov;60(11):3023-33. doi: 10.2337/db11-0816. Epub 2011 Sep 20. Diabetes. 2011. PMID: 21933988 Free PMC article.
-
Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy.Prog Mol Biol Transl Sci. 2017;148:67-85. doi: 10.1016/bs.pmbts.2017.02.004. Epub 2017 Mar 14. Prog Mol Biol Transl Sci. 2017. PMID: 28662829 Review.
-
Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4320-6. doi: 10.1167/iovs.09-4851. Epub 2010 Mar 10. Invest Ophthalmol Vis Sci. 2010. PMID: 20220057 Free PMC article.
Cited by
-
Matrix metalloproteinase-9 and vascular endothelial growth factor expression change in experimental retinal neovascularization.Int J Ophthalmol. 2016 Jun 18;9(6):804-8. doi: 10.18240/ijo.2016.06.02. eCollection 2016. Int J Ophthalmol. 2016. PMID: 27366678 Free PMC article.
-
Alterations in the polysialylated neural cell adhesion molecule and retinal ganglion cell density in mice with diabetic retinopathy.Int J Ophthalmol. 2018 Oct 18;11(10):1608-1615. doi: 10.18240/ijo.2018.10.06. eCollection 2018. Int J Ophthalmol. 2018. PMID: 30364237 Free PMC article.
-
The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina.J Diabetes Res. 2013;2013:658548. doi: 10.1155/2013/658548. Epub 2013 Apr 10. J Diabetes Res. 2013. PMID: 23671886 Free PMC article.
-
Mechanisms of macular edema.Front Med (Lausanne). 2023 Mar 7;10:1128811. doi: 10.3389/fmed.2023.1128811. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36960343 Free PMC article. Review.
-
Eucalyptol Inhibits Amyloid-β-Induced Barrier Dysfunction in Glucose-Exposed Retinal Pigment Epithelial Cells and Diabetic Eyes.Antioxidants (Basel). 2020 Oct 15;9(10):1000. doi: 10.3390/antiox9101000. Antioxidants (Basel). 2020. PMID: 33076507 Free PMC article.
References
-
- Klein R. Diabetic retinopathy. Annu Rev Public Health. 1996;17:137–158. - PubMed
-
- Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, Tsilibary EC. Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci. 1995;36:2358–2367. - PubMed
-
- Dosso AA, Leuenberger PM, Rungger-Brändle E. Remodeling of retinal capillaries in the diabetic hypertensive rat. Invest Ophthalmol Vis Sci. 1999;40:2405–2410. - PubMed
-
- Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242–260. - PubMed
-
- Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2:71–98. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous